Citius Pharmaceuticals- Warrants(02/08/2022) Receivables

Citius Pharmaceuticals- Warrants(02/08/2022) (CTXRW) currently reports a receivables of $690K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Citius Pharmaceuticals- Warrants(02/08/2022)'s receivables history and peer comparisons.

Citius Pharmaceuticals- Warrants(02/08/2022)'s receivables changed from $0 to $690K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Citius Pharmaceuticals- Warrants(02/08/2022) reported $690K in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $690K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Citius Pharmaceuticals- Warrants(02/08/2022), and consider following CTXRW for alerts when major investors trade the stock.

Citius Pharmaceuticals- Warrants(02/08/2022) is classified in the Healthcare sector. On receivables, it currently shows $690K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CTXRW with unrelated industries.